Latest filing: Neuland Laboratories Ltd - 524558 - Intimation Under Regulation 30 Of SEBI Listing Regulations
ObservedCompany dossier
Neuland Laboratories
NSE:NEULANDLAB · ISIN INE794A01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Neuland Laboratories
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹398 Cr · PAT ₹101.6 Cr.
Exchange XBRLLatest ownership: promoter group 32.62% and public 67.38% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Neuland Laboratories Limited
Agency sourceMaterial events
Open timeline →What changed recently
Observed
Source filing Neuland Laboratories Ltd - 524558 - Intimation Under Regulation 30 Of SEBI Listing Regulations
BSE · exchange filing
Observed
Source filing Updates - Neuland Laboratories Limited
NSE · exchange filing
Observed
Source filing Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Neuland Laboratories Limited
NSE · conference call
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹398 Cr
- Profit after tax
- ₹101.6 Cr
- EPS
- ₹79.18
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 32.62%
- Public
- 67.38%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL